NCT02986750View on ClinicalTrials.gov

Influence of Three Different Formulations of Lachrymal Substitutes on Tear Film Thickness and Other Signs and Symptoms in Patients With Moderate to Severe Dry Eye Syndrome

PHASE4CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

February 13, 2016

Primary Completion Date

March 23, 2017

Study Completion Date

March 23, 2017

Conditions

Dry Eye Syndromes

Interventions

DEVICE

Thealoz Duo Eye Drops

Manufacturer: Laboratoires Thea, France

DEVICE

Optive Eye Drops

Manufacturer: Allergan Pharmaceuticals, Ireland

DEVICE

Systane Ultra Eye Drops

Manufacturer: Alcon Pharma GmbH

Trial Locations (1)

1090

Department of Clinical Pharmacology, Medical University of Vienna, Vienna

All Listed Sponsors

lead

Medical University of Vienna

OTHER

NCT02986750 - Influence of Three Different Formulations of Lachrymal Substitutes on Tear Film Thickness and Other Signs and Symptoms in Patients With Moderate to Severe Dry Eye Syndrome | Biotech Hunter | Biotech Hunter